Market analytics and operational performance indicators
Rocket Lab SEC Filings
Browse Rocket Lab filings, review key metrics, and open source documents from one place.
SEC Command Deck
Use this feed to separate quarterly and annual operating disclosures from one-off event filings and insider ownership changes before opening full analysis or source documents.
What matters now
Latest Filings
Read the brief first, then open the full filing only when you need document-level detail.
Alexander R. Slusky, a Director at Rocket Lab USA Inc., disposed of 20,000 common shares via gift (code G) on 12/23/2025 at $0 per share. Post-transaction, direct holdings are 68,849 shares and indirect holdings are 534,675 shares via family entity. This is a neutral signal as gift transactions typically do not reflect market confidence.
Adam C. Spice, Chief Financial Officer of Rocket Lab USA Inc., disposed of 1,470 shares of common stock via gift on December 23, 2025. Following the transaction, he beneficially owns 1,993,903 shares directly. This gift is a neutral signal, as it does not reflect market buying or selling activity.
Rocket Lab director Edward H. Frank filed Form 144 to sell 2,500 common shares acquired via RSU vesting on 9/2/2023. Aggregate market value is $193,472 with no sales in the past 3 months. This discloses routine insider selling activity relevant for monitoring executive confidence.
Rocket Lab Director Nina Armagno sold 27,314 shares of common stock on December 19, 2025, at weighted average prices ranging from $60.99 to $70.18, reducing her direct holdings to 108,940 shares. The sales were executed automatically pursuant to a Rule 10b5-1 trading plan adopted on September 19, 2025. This is a neutral signal as it is a pre-scheduled sale.
Jon A. Olson, Director of Rocket Lab USA Inc., sold 15,000 common shares on 12/19/2025 at prices from $61.12-$70.20, totaling ~$1.02M. The transactions were automatic under a Rule 10b5-1 plan adopted 9/19/2025. Neutral signal due to pre-planned nature.
Merline Saintil, Director at Rocket Lab USA, sold 5,000 shares of common stock at $65 per share on 12/19/2025. The sale was automatic under a Rule 10b5-1 trading plan adopted 9/17/2025. Neutral signal due to pre-scheduled nature.
Rocket Lab entered a $816M agreement with the Space Development Agency (SDA) on Dec 17, 2025, to design, manufacture, and sustain 18 satellites for the Tracking Layer Tranche 3 program. The contract has a $806M base and $10M options, with work starting immediately and final delivery by 2029. It bolsters Rocket Lab's defense backlog.
Rocket Lab director Nina Armagno filed Form 144 to sell 27,314 common shares acquired via RSU vesting on 10/30/2025, with aggregate value of $1,636,654.88. The sale follows a Rule 10b5-1 trading plan adopted 09/19/2025, with no prior sales in the past 3 months. This routine insider transaction provides liquidity from compensation with minimal impact given shares outstanding of 534M.
Rocket Lab Director Jon Olson filed Form 144 on 2025-12-19 notifying proposed sale of 30,205 common shares acquired via PSUs on 2024-08-22, valued at $1,809,883.60. Sale under Rule 10b5-1 plan adopted 2025-09-19; he sold 60,400 shares on 2025-11-20 for $2.72M. Routine insider disclosure signals no material adverse info.
Rocket Lab director Merline A. Saintil filed Form 144 to sell 5,000 common shares on 12/19/2025, valued at $299,600, from 2023 RSUs. This follows sales of 30,000 shares in early December 2025 totaling ~$1.73M, all under a 10b5-1 plan adopted 09/17/2025. Routine disclosure for insiders with negligible impact on 534M outstanding shares.
Director Slusky gifted 20,000 shares ($0) from direct holdings.
Key Telemetry
- • Gift of 20,000 shares (23% of pre-transaction direct holdings of ~88,849; negligible vs. total ~603k shares).
- • Neutral gift to controlled family entity (Abalone Cove LLLP), not a market sale.
CFO Adam Spice gifted 1,470 shares ($0 value).
Key Telemetry
- • Small gift of 1,470 shares represents ~0.07% of post-transaction direct holdings of 1,993,903 shares.
- • Neutral gift transaction (code G at $0), not a market sale or purchase.
Director Edward Frank to sell 2,500 RKLB shares worth $193K.
Key Telemetry
- • Director Edward H. Frank to sell 2,500 common shares.
- • Shares from RSU vesting on 09/02/2023; value $193,471.75 (~$77.39/share).
Director Nina Armagno sold 27,314 shares (~$1.9M) via 10b5-1 plan.
Key Telemetry
- • Sold 27,314 shares (~20% of prior holdings), retaining 108,940 shares.
- • Executed via 10b5-1 plan adopted Sep 19, 2025; standard scheduled sales.
Director Olson sold 15,000 shares (~$1.02M) via 10b5-1 plan.
Key Telemetry
- • Sold 15,000 shares (~4.1% of post-sale direct holdings of 360,835)
- • 10b5-1 plan sales adopted Sep 19, 2025; standard scheduled divestiture
Director Saintil sold 5,000 shares ($325K) via 10b5-1 plan.
Key Telemetry
- • Sold 5,000 shares (~1.3% of post-sale direct holdings of 388,529 shares)
- • Automatic sale under 10b5-1 plan adopted Sep 17, 2025 (first referenced here)
Rocket Lab awarded $816M SDA contract for 18 Tracking Layer Tranche 3 satellites
Key Telemetry
- • $816M total contract value ($806M base + $10M options) with SDA
- • 18 satellites for Tracking Layer Tranche 3 program
Director Nina Armagno to sell 27,314 RKLB shares worth $1.64M under 10b5-1 plan.
Key Telemetry
- • Nina Armagno (Director) to sell 27,314 common shares, market value $1,636,654.88 (~$59.93/share).
- • Shares from RSUs vested 10/30/2025; no payment details needed.
Director Jon Olson files Form 144 to sell 30,205 RKLB shares worth $1.81M.
Key Telemetry
- • Jon Olson (Director) to sell 30,205 common shares, market value $1,809,883.60 (~$59.90/share).
- • Shares acquired 2024-08-22 via Performance Stock Units.
Director Saintil files Form 144 to sell 5,000 RKLB shares under 10b5-1 plan.
Key Telemetry
- • Director Merline Saintil to sell 5,000 shares (~$299,600) on 12/19/2025.
- • Recent sales: 30,000 shares in Dec 2025 for $1.73M total.